FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2913662425> ?p ?o ?g. }

• W2913662425 endingPage "47" @default.
• W2913662425 startingPage "38" @default.
• W2913662425 abstract "The non-medical use (NMU) of pharmaceuticals is increasing internationally, along with mortality. Previous research indicates that end-users access pharmaceuticals through social networks, however little is known about supplier sources particularly outside the US. This study examined sourcing and motivations among a sample of people involved in pharmaceutical diversion and supply in Australia. Semi-structured, telephone interviews were conducted with 51 people involved in supplying pharmaceuticals in the previous six months. Multi-stage recruitment involved the distribution of flyers to participants of two Australian drug-monitoring programs: the Ecstasy and related Drugs Reporting System (capturing regular psycho-stimulant users) and the Illicit Drug Reporting System (capturing people who regularly inject drugs), followed by a screening of interested participants. Interviews were audio-recorded, transcribed and analysed using a mixed methods approach. First, correlates of drug sourcing and motivations were examined including demographics, frequency and quantity of supply. Second, thematic analysis of the qualitative data was undertaken on strategies for obtaining the drugs and motivating factors. Drug supplies were sourced from a variety of medical and non-medical sources, primarily legitimately obtained prescriptions (47%), friends or family (18%) and dealers (14%). Suppliers using medical sources were more likely to be unemployed/retired and reported supplying for therapeutic purposes, while suppliers using non-medical sources were more likely to be employed/students, earned higher incomes and reported supplying for recreational purposes. Those who sourced via doctor shopping (IRR = 47.5) and friends and family (IRR = 10.1) distributed higher quantities, while those who sourced legitimately obtained prescriptions (IRR = 0.1) and from illicit drug dealers (IRR = 0.0) distributed lower quantities. Similar proportions supplied for financial (65%) and altruistic (61%) reasons, however the latter supplied lower quantities (IRR = 0.1). This study offers novel insight into the diversion of pharmaceuticals from the supplier perspective. A nuanced policy approach is required to address varied supply practices by source and motive." @default.
• W2913662425 created "2019-02-21" @default.
• W2913662425 creator A5003771371 @default.
• W2913662425 creator A5004809640 @default.
• W2913662425 creator A5056409837 @default.
• W2913662425 date "2019-04-01" @default.
• W2913662425 modified "2023-09-25" @default.
• W2913662425 title "Drug sourcing and motivations among a sample of people involved in the supply of pharmaceutical drugs in Australia" @default.
• W2913662425 cites W1487507364 @default.
• W2913662425 cites W1929010380 @default.
• W2913662425 cites W1966630589 @default.
• W2913662425 cites W1968131624 @default.
• W2913662425 cites W1973900173 @default.
• W2913662425 cites W1974993909 @default.
• W2913662425 cites W1983883416 @default.
• W2913662425 cites W1998483125 @default.
• W2913662425 cites W2004828581 @default.
• W2913662425 cites W2006142658 @default.
• W2913662425 cites W2009414991 @default.
• W2913662425 cites W2021687566 @default.
• W2913662425 cites W2036930640 @default.
• W2913662425 cites W2049453270 @default.
• W2913662425 cites W2056680548 @default.
• W2913662425 cites W2060627771 @default.
• W2913662425 cites W2073539204 @default.
• W2913662425 cites W2079126110 @default.
• W2913662425 cites W2085218304 @default.
• W2913662425 cites W2087793458 @default.
• W2913662425 cites W2109349593 @default.
• W2913662425 cites W2117230821 @default.
• W2913662425 cites W2119344572 @default.
• W2913662425 cites W2129846155 @default.
• W2913662425 cites W2133674686 @default.
• W2913662425 cites W2135898465 @default.
• W2913662425 cites W2138560568 @default.
• W2913662425 cites W2154495710 @default.
• W2913662425 cites W2162832003 @default.
• W2913662425 cites W2162970837 @default.
• W2913662425 cites W2227095885 @default.
• W2913662425 cites W2265274736 @default.
• W2913662425 cites W2269501814 @default.
• W2913662425 cites W2275878851 @default.
• W2913662425 cites W2339300754 @default.
• W2913662425 cites W2511410176 @default.
• W2913662425 cites W2571444892 @default.
• W2913662425 cites W2579772603 @default.
• W2913662425 cites W2608512281 @default.
• W2913662425 cites W2789910588 @default.
• W2913662425 cites W2794421601 @default.
• W2913662425 cites W2794501770 @default.
• W2913662425 cites W2800278321 @default.
• W2913662425 cites W2806233781 @default.
• W2913662425 doi "https://doi.org/10.1016/j.drugpo.2019.01.022" @default.
• W2913662425 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30690223" @default.
• W2913662425 hasPublicationYear "2019" @default.
• W2913662425 type Work @default.
• W2913662425 sameAs 2913662425 @default.
• W2913662425 citedByCount "11" @default.
• W2913662425 countsByYear W29136624252019 @default.
• W2913662425 countsByYear W29136624252020 @default.
• W2913662425 countsByYear W29136624252021 @default.
• W2913662425 countsByYear W29136624252022 @default.
• W2913662425 crossrefType "journal-article" @default.
• W2913662425 hasAuthorship W2913662425A5003771371 @default.
• W2913662425 hasAuthorship W2913662425A5004809640 @default.
• W2913662425 hasAuthorship W2913662425A5056409837 @default.
• W2913662425 hasConcept C118552586 @default.
• W2913662425 hasConcept C144024400 @default.
• W2913662425 hasConcept C144133560 @default.
• W2913662425 hasConcept C149923435 @default.
• W2913662425 hasConcept C159110408 @default.
• W2913662425 hasConcept C162853370 @default.
• W2913662425 hasConcept C185592680 @default.
• W2913662425 hasConcept C190248442 @default.
• W2913662425 hasConcept C198531522 @default.
• W2913662425 hasConcept C2426938 @default.
• W2913662425 hasConcept C2779488553 @default.
• W2913662425 hasConcept C2780035454 @default.
• W2913662425 hasConcept C2780084366 @default.
• W2913662425 hasConcept C36289849 @default.
• W2913662425 hasConcept C43617362 @default.
• W2913662425 hasConcept C512399662 @default.
• W2913662425 hasConcept C71924100 @default.
• W2913662425 hasConcept C74196892 @default.
• W2913662425 hasConceptScore W2913662425C118552586 @default.
• W2913662425 hasConceptScore W2913662425C144024400 @default.
• W2913662425 hasConceptScore W2913662425C144133560 @default.
• W2913662425 hasConceptScore W2913662425C149923435 @default.
• W2913662425 hasConceptScore W2913662425C159110408 @default.
• W2913662425 hasConceptScore W2913662425C162853370 @default.
• W2913662425 hasConceptScore W2913662425C185592680 @default.
• W2913662425 hasConceptScore W2913662425C190248442 @default.
• W2913662425 hasConceptScore W2913662425C198531522 @default.
• W2913662425 hasConceptScore W2913662425C2426938 @default.
• W2913662425 hasConceptScore W2913662425C2779488553 @default.
• W2913662425 hasConceptScore W2913662425C2780035454 @default.
• W2913662425 hasConceptScore W2913662425C2780084366 @default.
• W2913662425 hasConceptScore W2913662425C36289849 @default.

• next